[

dcgi

]

Latest from dcgi

'Compliant with norms': India to WHO on cough syrups and Gambia kids' deaths

All four cough syrup samples of Maiden Pharmacueticals tested by the government have been found compliant with norms, the national drugs controller has said in a recent letter to the WHO.

Sonepat: Maiden Pharmaceuticals Limited factory in Sonepat district, Thursday, Oct. 6, 2022. A probe has been initiated by India's drug regulator after WHO issued an alert saying cough syrups manufactured by the Indian firm could potentially be linked to the death of children in Gambia. (PTI Photo)(PTI10_06_2022_000103B) (PTI)
Sonepat: Maiden Pharmaceuticals Limited factory in Sonepat district, Thursday, Oct. 6, 2022. A probe has been initiated by India's drug regulator after WHO issued an alert saying cough syrups manufactured by the Indian firm could potentially be linked to the death of children in Gambia. (PTI Photo)(PTI10_06_2022_000103B) (PTI)
Updated on Dec 16, 2022 12:16 PM IST

Gambia deaths: India says WHO's info ‘inadequate’ to determine aetiology

On October 13, Rutendo Kuwana from the WHO had written to the DCGI and sought to know the progress with the investigation of the manufacturer of the four cough syrups - the Sonipat-based Maiden Pharmaceuticals.

Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul, (AFP)
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul, (AFP)
Updated on Oct 15, 2022 11:54 PM IST
By | Edited by Aniruddha Dhar, New Delhi

‘Diligently following protocol’: Maiden Pharma breaks silence on Gambia deaths

Maiden Pharma's director Vivek Goyal said on Saturday, said the company has been in the business for over three decades and their products are not sold in domestic market. The company said it has the requisite export approvals for the products that have come under the scanner of drug authorities.

A health department team arrives at the Maiden Pharmaceuticals Ltd unit in Sonepat. (PTI)(HT_PRINT)
A health department team arrives at the Maiden Pharmaceuticals Ltd unit in Sonepat. (PTI)(HT_PRINT)
Updated on Oct 09, 2022 05:04 AM IST
By, New Delhi

Covovax granted EUA for children aged 7-12

The Drugs Controller General of India (DCGI), the country’s drugs regulator, on Tuesday granted emergency use authorisation (EUA) to India’s first indigenously developed mRNA vaccine against Covid-19 manufactured by Pune-based Gennova Biopharmaceuticals

Jalandhar: A health worker administers a dose of COVID-19 vaccine to a student, amid rise in coronavirus cases, at a government school, in Jalandhar, Monday, May 2, 2022. (PTI Photo) (PTI05_02_2022_000108B) (PTI)
Jalandhar: A health worker administers a dose of COVID-19 vaccine to a student, amid rise in coronavirus cases, at a government school, in Jalandhar, Monday, May 2, 2022. (PTI Photo) (PTI05_02_2022_000108B) (PTI)
Updated on Jun 29, 2022 01:34 AM IST

India clears Corbevax as a booster dose for adults

Corbevax can be administered as a Covid-19 booster dose for individuals aged 18 years and above, six months after they have been administered the second doses of Covishield or Covaxin, the DCGi said.

So far, 51.7 million doses of Corbevax have been administered to children across the country (FILE)
So far, 51.7 million doses of Corbevax have been administered to children across the country (FILE)
Published on Jun 04, 2022 11:56 PM IST
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Friday, January 27, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals